Christopher Sarchi's most recent trade in Replimune Group Inc was a trade of 3,749 Common Stock done at an average price of $8.0 . Disclosure was reported to the exchange on May 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Replimune Group Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 8.05 per share. | 20 May 2025 | 3,749 | 128,296 (0%) | 0% | 8.0 | 30,179 | Common Stock |
| Replimune Group Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 67,500 | 67,500 | - | - | Employee Stock Option (right to buy) | |
| Replimune Group Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 45,000 | 132,045 (0%) | 0% | 0 | Common Stock | |
| Replimune Group Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 10.78 per share. | 18 Nov 2024 | 5,207 | 87,045 (0%) | 0% | 10.8 | 56,131 | Common Stock |
| Replimune Group Inc | Christopher Sarchi | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 16 May 2024 | 2,218 | 92,252 (0%) | 0% | 6.5 | 14,350 | Common Stock |
| Replimune Group Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 66,675 | 66,675 | - | - | Employee Stock Option (right to buy) | |
| Replimune Group Inc | Christopher Sarchi | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 22,225 | 94,470 (0%) | 0% | 0 | Common Stock |